Dassault Systèmes SE (DASTY)

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2026

3DS: Half-year statement of the liquidity contract entered into with Oddo BHF SCA

Dassault Systèmes Announces 16th AAKRUTI Innovation Competition for Students Worldwide, Inspiring Innovations to Solve Global Challenges

Dassault Systèmes successfully issues €1 billion in bonds and refinances its revolving credit facility

Dassault Systèmes Partners with PariSanté Campus to Advance a Sovereign Healthcare Ecosystem in Europe

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of May 31, 2026

Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?

Dassault Systemes: Downgrade To Hold As The Timing To Growth Acceleration Is Uncertain

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2026

Combined General Shareholders' Meeting of May 20, 2026: availability of preliminary documents

Dassault Systèmes SE (DASTY) Q1 2026 Earnings Call Transcript

Dassault Systemes reports first-quarter results in line with estimates

Dassault Systèmes reports first quarter 2026 results in line with objectives and confirms full-year outlook